Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9249161 Bromodomain inhibitors and uses thereof

Patent 9249161 was granted and assigned to CONSTELLATION PHARMACEUTICALS INC on February, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

CONSTELLATION PHARMACEUTICALS INC

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Christopher G. Nasveschuk0

Alexander M. Taylor0

Alexandre Côté0

Brian K. Albrecht0

James Edmund Audia0

Jean-Christophe Harmange0

Michael Charles Hewitt0

Rishi G. Vaswani0

...

Date of Patent

February 2, 2016

0

Patent Application Number

139909060

Date Filed

December 2, 2011

0

Patent Citations Received

US Patent 11802131 Glutarimides for medical treatment

US Patent 11992531 C

0

0

0

US Patent 12091397 Dihydroquinolinones for medical treatment

0

US Patent 12076405 Heterocyclic degronimers for target protein degradation

0

US Patent 11753397 Cereblon binders for the degradation of ikaros

US Patent 11787802 Dihydrobenzimidazolones for medical treatment

Patent Primary Examiner

0

Patent abstract

The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9249161 Bromodomain inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool